Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
来自Mirum Pharmicals分析师评级的关键见解：你需要知道的
Analysts' ratings for Mirum Pharmaceuticals (NASDAQ:MIRM) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
4位分析师提供的分析师对Mirum Pharmicals（纳斯达克股票代码：MIRM）在上个季度的评级从看涨到看跌不等。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $55.25, a high estimate of $64.00, and a low estimate of $35.00. This current average represents a 19.93% decrease from the previous average price target of $69.00.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为55.25美元，最高估计为64.00美元，低估值为35.00美元。目前的平均价格比之前的平均目标价69.00美元下降了19.93％。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
A comprehensive examination of...
对金融专...
登录免费看全文
登录/注册